Atlas Compliance Blog

Latest insights and updates from Atlas Compliance

How the EU AI Act Will Reshape Global Business Compliance Strategies
September 9, 2025

How the EU AI Act Will Reshape Global Business Compliance Strategies

The European Union has introduced the AI Act, the first law designed to regulate artificial intelligence in a comprehensive way. This law will significantly change how businesses develop, purchase, and deploy AI systems. It also reshapes how compliance teams operate, requiring them to be proactive, thorough, and well-documented. In simple terms, the law demands that […]

Read More
What Solutions Can Ease Supplier Overload from Fragmented Compliance Data Requests
September 9, 2025

What Solutions Can Ease Supplier Overload from Fragmented Compliance Data Requests

tl;dr: In today’s global supply chain, compliance is no longer just about following rules. It is about managing trust, reducing risk, and keeping up with constant regulatory changes. Companies in industries such as pharmaceuticals, biotech, healthcare, and manufacturing are under pressure to prove that their suppliers and partners follow strict standards. Yet, one of the […]

Read More
Why NIS2 is Still Hard for Companies, Even with Automation Tools
September 8, 2025

Why NIS2 is Still Hard for Companies, Even with Automation Tools

tl;dr: NIS2 was made to make Europe safer on the internet; however, many firms still find it hard to meet the rules. The reasons include wide scope, differences between countries, unclear local rules, legacy systems, staff gaps, and complex supply chains. Automation helps, yet it cannot fix weak policies, unclear responsibilities, or poor data. Below […]

Read More
Do warning letters impact pharma stock investments?
September 5, 2025

Do warning letters impact pharma stock investments?

tl;dr: Yes, warning letters and multiple inspections affect pharma stocks. They create risks like production disruption, export bans, recalls, legal costs, reputation loss, and delayed approvals. In recent years, big pharma companies have received warning letters that moved markets. Before investing, always check a company’s inspection history, warning-letter responses, recall records, and remediation plans. What […]

Read More
How Does the FDA’s Drug Supply Chain Security Act Affect Your Business?​
September 3, 2025

How Does the FDA’s Drug Supply Chain Security Act Affect Your Business?​

tl;dr: The FDA’s DSCSA ensures prescription drugs in the U.S. are traceable to prevent counterfeit or unsafe products. By 2025, all manufacturers, distributors, and most pharmacies must comply with serialization, verification, and tracing requirements. Businesses can use tools like Atlas Compliance to simplify compliance and protect the supply chain. The Drug Supply Chain Security Act […]

Read More
Why Are QA Teams Choosing Atlas AI Copilot in 2025?
September 3, 2025

Why Are QA Teams Choosing Atlas AI Copilot in 2025?

tl;dr: In 2025, inspections are tougher and often unannounced. Atlas AI Copilot helps QA teams see what each inspector focuses on, their common observations, and gives a step-by-step prep guide—so teams stay ready and avoid surprises. If you work in pharma or biologics, 2025 feels like the year inspections got real again. FDA is inspecting […]

Read More